Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center
  • Home
  • Articles
  • Issues

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Genetics
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues

Share

December 2015; 1 (4) Clinical/Scientific NotesOpen Access

Mutation in PNKP presenting initially as axonal Charcot-Marie-Tooth disease

José Luiz Pedroso, Clarissa R.R. Rocha, Lucia I. Macedo-Souza, Vitor De Mario, Wilson Marques, Orlando G.P. Barsottini, Acary S. Bulle Oliveira, Carlos F.M. Menck, Fernando Kok
First published October 22, 2015, DOI: https://doi.org/10.1212/NXG.0000000000000030
José Luiz Pedroso
From the Department of Neurology (J.L.P., O.G.P.B., A.S.B.O.), Federal University of São Paulo, São Paulo, Brazil; Department of Microbiology (C.R.R.R., C.F.M.M.), Institute of Biomedical Sciences, and Center for Human Genome and Stem Cell Research (L.I.M.-S., F.K.), Institute of Biosciences, University of São Paulo, São Paulo, Brazil; Mendelics Genomic Analysis (V.D.M., F.K.), São Paulo, Brazil; Department of Neurology (W.M.), University of São Paulo School of Medicine, Ribeirão Preto, Brazil; and Department of Neurology (F.K.), University of São Paulo School of Medicine, São Paulo, Brazil.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clarissa R.R. Rocha
From the Department of Neurology (J.L.P., O.G.P.B., A.S.B.O.), Federal University of São Paulo, São Paulo, Brazil; Department of Microbiology (C.R.R.R., C.F.M.M.), Institute of Biomedical Sciences, and Center for Human Genome and Stem Cell Research (L.I.M.-S., F.K.), Institute of Biosciences, University of São Paulo, São Paulo, Brazil; Mendelics Genomic Analysis (V.D.M., F.K.), São Paulo, Brazil; Department of Neurology (W.M.), University of São Paulo School of Medicine, Ribeirão Preto, Brazil; and Department of Neurology (F.K.), University of São Paulo School of Medicine, São Paulo, Brazil.
BcD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucia I. Macedo-Souza
From the Department of Neurology (J.L.P., O.G.P.B., A.S.B.O.), Federal University of São Paulo, São Paulo, Brazil; Department of Microbiology (C.R.R.R., C.F.M.M.), Institute of Biomedical Sciences, and Center for Human Genome and Stem Cell Research (L.I.M.-S., F.K.), Institute of Biosciences, University of São Paulo, São Paulo, Brazil; Mendelics Genomic Analysis (V.D.M., F.K.), São Paulo, Brazil; Department of Neurology (W.M.), University of São Paulo School of Medicine, Ribeirão Preto, Brazil; and Department of Neurology (F.K.), University of São Paulo School of Medicine, São Paulo, Brazil.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vitor De Mario
From the Department of Neurology (J.L.P., O.G.P.B., A.S.B.O.), Federal University of São Paulo, São Paulo, Brazil; Department of Microbiology (C.R.R.R., C.F.M.M.), Institute of Biomedical Sciences, and Center for Human Genome and Stem Cell Research (L.I.M.-S., F.K.), Institute of Biosciences, University of São Paulo, São Paulo, Brazil; Mendelics Genomic Analysis (V.D.M., F.K.), São Paulo, Brazil; Department of Neurology (W.M.), University of São Paulo School of Medicine, Ribeirão Preto, Brazil; and Department of Neurology (F.K.), University of São Paulo School of Medicine, São Paulo, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wilson Marques Jr
From the Department of Neurology (J.L.P., O.G.P.B., A.S.B.O.), Federal University of São Paulo, São Paulo, Brazil; Department of Microbiology (C.R.R.R., C.F.M.M.), Institute of Biomedical Sciences, and Center for Human Genome and Stem Cell Research (L.I.M.-S., F.K.), Institute of Biosciences, University of São Paulo, São Paulo, Brazil; Mendelics Genomic Analysis (V.D.M., F.K.), São Paulo, Brazil; Department of Neurology (W.M.), University of São Paulo School of Medicine, Ribeirão Preto, Brazil; and Department of Neurology (F.K.), University of São Paulo School of Medicine, São Paulo, Brazil.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Orlando G.P. Barsottini
From the Department of Neurology (J.L.P., O.G.P.B., A.S.B.O.), Federal University of São Paulo, São Paulo, Brazil; Department of Microbiology (C.R.R.R., C.F.M.M.), Institute of Biomedical Sciences, and Center for Human Genome and Stem Cell Research (L.I.M.-S., F.K.), Institute of Biosciences, University of São Paulo, São Paulo, Brazil; Mendelics Genomic Analysis (V.D.M., F.K.), São Paulo, Brazil; Department of Neurology (W.M.), University of São Paulo School of Medicine, Ribeirão Preto, Brazil; and Department of Neurology (F.K.), University of São Paulo School of Medicine, São Paulo, Brazil.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Acary S. Bulle Oliveira
From the Department of Neurology (J.L.P., O.G.P.B., A.S.B.O.), Federal University of São Paulo, São Paulo, Brazil; Department of Microbiology (C.R.R.R., C.F.M.M.), Institute of Biomedical Sciences, and Center for Human Genome and Stem Cell Research (L.I.M.-S., F.K.), Institute of Biosciences, University of São Paulo, São Paulo, Brazil; Mendelics Genomic Analysis (V.D.M., F.K.), São Paulo, Brazil; Department of Neurology (W.M.), University of São Paulo School of Medicine, Ribeirão Preto, Brazil; and Department of Neurology (F.K.), University of São Paulo School of Medicine, São Paulo, Brazil.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos F.M. Menck
From the Department of Neurology (J.L.P., O.G.P.B., A.S.B.O.), Federal University of São Paulo, São Paulo, Brazil; Department of Microbiology (C.R.R.R., C.F.M.M.), Institute of Biomedical Sciences, and Center for Human Genome and Stem Cell Research (L.I.M.-S., F.K.), Institute of Biosciences, University of São Paulo, São Paulo, Brazil; Mendelics Genomic Analysis (V.D.M., F.K.), São Paulo, Brazil; Department of Neurology (W.M.), University of São Paulo School of Medicine, Ribeirão Preto, Brazil; and Department of Neurology (F.K.), University of São Paulo School of Medicine, São Paulo, Brazil.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Kok
From the Department of Neurology (J.L.P., O.G.P.B., A.S.B.O.), Federal University of São Paulo, São Paulo, Brazil; Department of Microbiology (C.R.R.R., C.F.M.M.), Institute of Biomedical Sciences, and Center for Human Genome and Stem Cell Research (L.I.M.-S., F.K.), Institute of Biosciences, University of São Paulo, São Paulo, Brazil; Mendelics Genomic Analysis (V.D.M., F.K.), São Paulo, Brazil; Department of Neurology (W.M.), University of São Paulo School of Medicine, Ribeirão Preto, Brazil; and Department of Neurology (F.K.), University of São Paulo School of Medicine, São Paulo, Brazil.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Mutation in PNKP presenting initially as axonal Charcot-Marie-Tooth disease
José Luiz Pedroso, Clarissa R.R. Rocha, Lucia I. Macedo-Souza, Vitor De Mario, Wilson Marques, Orlando G.P. Barsottini, Acary S. Bulle Oliveira, Carlos F.M. Menck, Fernando Kok
Neurol Genet Dec 2015, 1 (4) e30; DOI: 10.1212/NXG.0000000000000030

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
881

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

PNKP (polynucleotide kinase 3′-phosphatase, OMIM #605610) product is involved in the repair of strand breaks and base damage in the DNA molecule mainly caused by radical oxygen species. Deleterious variants affecting this gene have been previously associated with microcephaly, epilepsy, and developmental delay.1 According to a previous report, homozygous loss-of-function substitution in PNKP was associated with cerebellar atrophy, neuropathy, microcephaly, epilepsy, and intellectual disability.2 Recently, whole-exome sequencing (WES) performed in a cohort of Portuguese families with ataxia with oculomotor apraxia (AOA) disclosed pathogenic variants in PNKP in 11 individuals. Other clinical features in that study included neuropathy, dystonia, cognitive impairment, decreased vibration sense, pyramidal signs, mild elevation in α-fetoprotein, and low levels of albumin. This condition was named AOA type 4 (OMIM #616267), as the phenotype of AOA has been previously associated with 3 other genes: APTX, SETX, and PIK3R5.3 Altogether, these reports demonstrate the great phenotypic diversity associated with PNKP mutations. In this article, we further enlarge this variability by demonstrating that early-onset axonal sensory-motor neuropathy (or axonal Charcot-Marie-Tooth (CMT) disease) followed years later by ataxia without oculomotor apraxia can be caused by deleterious variants in PNKP. Full consent was obtained from the patient and his parents for this publication. This study was approved by institutional ethics committees.

Case description.

A 17-year-old boy presented with early onset of nonprogressive gait abnormalities and feet deformities observed since the first years of life. After the age of 9 years, his gait deteriorated. The combination of pes cavus, hammertoes, and absent deep tendon reflexes together with the nerve conduction velocity test and EMG disclosing sensory-motor axonal neuropathy prompted the diagnosis of axonal CMT disease; no ataxia was observed. Parents were nonconsanguineous and family history was unremarkable. Molecular analysis for axonal CMT genes, including MFN2, GDAP1, MPZ, NEFL, and GJB1, was negative. During the last 5 years, steppage gait, mild ataxia, and slurred speech were observed, and pes cavus and hammertoes became prominent (figure 1, A–C); he never had oculomotor apraxia. Brain MRI depicted mild cerebellar atrophy (figure 1, D and E). Other recessive ataxias were excluded.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1 Patient at 17 years of age

Note pes cavus and hammertoes (A, B). In addition, there is bilateral peroneal and calf muscle atrophy (C). These features are characteristic of Charcot-Marie-Tooth disease. Axial T2-weighted brain MRI disclosed mild cerebellar atrophy (arrows) (D, E).

WES was performed with the exome capture kit Nextera Sure Select (Agilent Technologies, Santa Clara, CA) and the sequencing platform Illumina HiSeq2500 (Illumina, San Diego, CA). Sequence alignment and variant call coverage of target bases with more than 10 reads was 96.4%. A homozygous variant (c.1221_1223delCAC [p.Thr408del]) that was previously reported in compound heterozygosity in a patient with AOA4 was detected, and his parents were heterozygous for this variant.3

Functional analysis.

PNKP-mutated cells (CMT01SP) were more sensitive to both chemicals than wild-type cells (normal human fibroblasts), as observed on a viability (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay (figure e-1, A and B at Neurology.org/ng) and by the higher frequency of sub-G1 cells, an indicator of apoptosis (figure e-1C). The increased apoptosis induced by doxorubicin and H2O2 was confirmed by higher caspase-3 activity in the mutated cells (figure e-1D). Furthermore, the cell cycle kinetics were highly disturbed upon genotoxic drug treatment in the patient cell line, where there is clear, persistent G2 arrest, especially after doxorubicin treatment (figure e-1E). In addition, to evaluate how the PNKP mutation affects the DNA repair capacity of these cells, we detected the levels of phosphorylation of histone H2AX (γH2AX)—widely used as a DNA damage marker—after treatment with H2O2 and doxorubicin.4 As clearly seen in figure e-1, F–H, after 24 hours, the PNKP-mutated cells showed a much larger population of γH2AX-positive cells than the control cells, and this persisted even after 72 hours, indicating that the patient's cells were unable to efficiently repair DNA lesions caused by H2O2 and doxorubicin. Taken together, those results strongly indicate that the (c.1221_1223delCAC [p.Thr408del]) PNKP mutation has a substantial functional effect on protein activity, impairing DNA repair capacity on both base excision repair (BER) and non-homologous end joining (NHEJ) pathways.5,6

Discussion.

Recessive CMT, also known as CMT4, represents less than 10% of CMT cases. At least 22 genes are associated with CMT4, which can be axonal or demyelinating. Because clinical manifestations of CMT are usually not gene specific, molecular diagnosis is not a straightforward task and many patients remain without a genetic background.7 Next-generation sequencing will help to increase the number of genes associated with these disorders.

This report expands the phenotypic variability associated with mutations in PNKP, which spans from a more severe presentation of microcephaly, epilepsy, and mental retardation at one end of the spectrum to a milder, CMT-like phenotype with ataxia but no oculomotor apraxia, epilepsy, or cognitive impairment, as seen in our patient, at the other side of the spectrum. In addition, it demonstrates that even with a milder phenotype, as occurred in our patient, DNA repair capacity is impaired on both BER and NHEJ pathways.

Footnotes

  • Supplemental data at Neurology.org/ng

  • Author contributions: Dr. Pedroso contributed to article conception, organization, and execution, as well as writing of the text and review and critique of the manuscript. Ms. Rocha contributed to functional evaluation experiments, as well as writing of the text and review and critique of the manuscript. Dr. Macedo-Souza contributed to genetic evaluation execution, writing of the text, and review and critique of the manuscript. Dr. De Mario contributed to genetic evaluation execution, writing of the text, and review and critique of the manuscript. Dr. Marques contributed to article conception, organization, and execution, as well as writing of the text and review and critique of the manuscript. Dr. Barsottini contributed to article conception, organization, and execution, as well as writing of the text and review and critique of the manuscript. Dr. Oliveira contributed to article conception, organization, and execution, as well as writing of the text and review and critique of the manuscript. Dr. Menck contributed to writing of the text and review and critique of the manuscript. Dr. Kok contributed to article conception, organization, and execution, as well as genetic evaluation execution, writing of the text, and review and critique of the manuscript.

  • Study funding: CEPID-FAPESP, FAPESP (Sao Paulo, SP) and CNPq (Brasilia, DF).

  • Disclosure: Dr. Pedroso, Ms. Rocha, and Dr. Macedo-Souza report no disclosures. Dr. De Mario has been an employee of Mendelics Genomic Analysis. Dr. Marques has served on the editorial board of the Arquivos de Neuro-Psiquiatria. Dr. Barsottini has been an employee of the Federal University of São Paulo. Dr. Oliveira reports no disclosures. Dr. Menck serves on the editorial board of Genetics and Molecular Biology, edited by the Brazilian Genetics Society, and has received research support from BRASKEM, Natura, FAPESP, CNPq, and CAPEs. Dr. Kok has served on the editorial board of Arquivos de Neuro-Psiquiatria, holds a patent for Methylmalonic acid determination by tandem mass spectrometry using stable isotope, and has been an employee of Medelics Genomic Analysis. Go to Neurology.org/ng for full disclosure forms. The Article Processing Charge was paid by the authors.

  • Received August 1, 2015.
  • Accepted in final form September 1, 2015.
  • © 2015 American Academy of Neurology

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

References

  1. 1.↵
    1. Shen J,
    2. Gilmore EC,
    3. Marshall CA,
    4. et al
    . Mutations in PNKP cause microcephaly, seizures and defects in DNA repair. Nat Genet 2010;42:245–249.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Poulton C,
    2. Oegema R,
    3. Heijsman D,
    4. et al
    . Progressive cerebellar atrophy and polyneuropathy: expanding the spectrum of PNKP mutations. Neurogenetics 2013;14:43–51.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Bras J,
    2. Alonso I,
    3. Barbot C,
    4. et al
    . Mutations in PNKP cause recessive ataxia with oculomotor apraxia type 4. Am J Hum Genet 2015;96:474–479.
    OpenUrl
  4. 4.↵
    1. Cleaver JE
    . γH2Ax: biomarker of damage or functional Participant in DNA repair “all that glitters is not gold!” Photochem Photobiol 2011;87:1230–1239.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Ortolan TG,
    2. Menck CF
    . UVB-induced cell death signaling is associated with G1-S progression and transcription inhibition in primary human fibroblasts. PLoS One 2013;8:e76936.
    OpenUrl
  6. 6.↵
    1. Wood RD,
    2. Mitchell M,
    3. Lindahl T
    . Human DNA repair genes Mutat Res 2005;577:275–283.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Zimoń M,
    2. Battaloğlu E,
    3. Parman Y,
    4. et al
    . Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach. Neurogenetics 2015;16:33–42.
    OpenUrlCrossRefPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Association Between Fluctuations in Blood Lipid Levels Over Time With Incident Alzheimer Disease and Alzheimer Disease–Related Dementias

Dr. Sevil Yaşar and Dr. Behnam Sabayan

► Watch

Topics Discussed

  • All Neuromuscular Disease
  • All Genetics
  • Gait disorders/ataxia
  • Peripheral neuropathy

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Clinical/Scientific Notes
    Expanding the ataxia with oculomotor apraxia type 4 phenotype
    Martin Paucar, Helena Malmgren, Malcolm Taylor et al.
    Neurology Genetics, January 21, 2016
  • Clinical Implications of Neuroscience Research
    DNA damage response
    Selected review and neurologic implications
    Elizabeth A. Coon, Eduardo E. Benarroch et al.
    Neurology, January 19, 2018
  • Article
    Novel PNKP mutations causing defective DNA strand break repair and PARP1 hyperactivity in MCSZ
    Ilona Kalasova, Hana Hanzlikova, Neerja Gupta et al.
    Neurology: Genetics, March 25, 2019
  • Articles
    Ataxia with oculomotor apraxia type 2
    A clinical, pathologic, and genetic study
    C. Criscuolo, L. Chessa, S. Di Giandomenico et al.
    Neurology, April 24, 2006
Neurology Genetics: 9 (6)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Genetics | Online ISSN: 2376-7839

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise